Experiment 1306461

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

FUROSTAN-3-BETA-YL -O-BETA-D-GLUCOPYRANOSYL-(1 →3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-6-ALPHA-HYDROXY-22-ALPHA- -METHOXY-5-ALPHA:SPIROSTAN-3 BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-LUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:24(S)-25(S)-24-[(BETA-D-GLUCOPYRANOSYL)OXY]-5-ALPHA:SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-6-ALPHA-HYDROXY-5-ALPHA:FUROSTAN, 3-BETA-6-ALPHA-26-TRIYL TRIS-BETA-D-GLUCOPYRANOSIDE:25(R)-22-ALPHA-METHOXY-5-ALPHA:FUROSTAN-3-BETA-D-YL O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-22-ALPHA-METHOXY-5-ALPHA:SPIROSTANE-3-BETA-D-6-ALPHA-DIYL BIS-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-23-HYDROXY-5-ALPHA:SPIROSTAN-3-BETA-YL-BETA-D-FUCOPYRANOSIDE:23(S)-25(R)- 6-ALPHA-[(BETA-D--GLUCOPYRANOSYL)OXY]-23-HYDROXY-5- ALPHA:SPIROSTAN-6-ALPHA-YL-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-3-BETA-D-23-DIHYDROXY-5-ALPHA:

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismFurcraea foetida (AGAVACEAE)
CitationYOKOSUKA,A: SANO,T: HASHIMOTO,K: SAKAGAMI,H: MIMAKI,Y:. (2009). STEROIDAL GLYCOSIDES FROM FURCRAEA FOETIDA AND THEIR CYTOTOXIC ACTIVITY. 57(10)
Amount utilized
Compound isolated
Dose amount20 MCG
Number3
Qualitative resultINACTIVE
AnimalCELL CULTURE
Per unitML
Dose expressionCONC USED